Brief: Edwards Lifesciences Q3 Adjusted EPS USD 0.67 Vs. IBES Estimate USD 0.64
24/10/2024 21:21
Oct 24 (Reuters) - Edwards Lifesciences Q3 gross profit USD 1,091.5 million. * Q3 sales USD 1,354.4 million vs. IBES estimate USD 1,521 million * Q3 EPS USD 5.13 * Q3 adjusted gross margin 80.7%
Recent news on Edwards Lifesciences
See all newsFDA flags Edwards heart-valve delivery system issue after death, injury (updated)
FDA flags Edwards heart-valve delivery system issue after death, injury
Brief: FDA Aware Edwards Lifesciences Issued Letter Recommending Some Delivery Systems Used For Sapien M3 Transcatheter Mitral Valve Replacement Be Removed
Brief: Edwards Lifesciences Corporation - Maintains Confidence In Financial Guidance For 2026
U.S. RESEARCH ROUNDUP-Deckers Brands, Rollins, United Rentals